Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Alon D. Altman"'
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1348-1358 (2024)
Background: In Canada, individuals with gynecologic reproductive organs (ovaries, fallopian tubes, uterus) over the age of 70 comprise a large proportion of epithelial ovarian cancer patients. These patients often have co-morbidities, polypharmacy, o
Externí odkaz:
https://doaj.org/article/5f0eb2b7d88147e2b65e9c279627d745
Autor:
Nourah Ibrahim, Alon D. Altman
Publikováno v:
Gynecologic Oncology Reports, Vol 56, Iss , Pp 101519- (2024)
Externí odkaz:
https://doaj.org/article/0cb1bd3c16074e60baf29de78aed5874
Autor:
Christa Aubrey, Gregory R. Pond, Limor Helpman, Danielle Vicus, Laurie Elit, Marie Plante, Susie Lau, Janice S. Kwon, Alon D. Altman, Karla Willows, Tomer Feigenberg, Jeanelle Sabourin, Vanessa Samouelian, Laurence Bernard, Norah Cockburn, Nora-Beth Saunders, Sabrina Piedimonte, Ly-Ann Teo-Fortin, Soyoun Rachel Kim, Noor Sadeq, Ji-Hyun Jang, Sarah Shamiya, Gregg Nelson
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 1977-1985 (2023)
Minimally invasive surgery for the treatment of macroscopic cervical cancer leads to worse oncologic outcomes than with open surgery. Preoperative conization may mitigate the risk of surgical approach. Our objective was to describe the oncologic outc
Externí odkaz:
https://doaj.org/article/0d3954a81af94f889a37742b30ebd835
Autor:
Kelcey Winchar, Pascal Lambert, Kirk J. McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Decker, Mark W. Nachtigal, Alon D. Altman
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9365-9376 (2022)
(1) Background: The primary objective of this study was to examine the rate of genetic referral, BRCA testing, and BRCA positivity amongst all patients with high-grade serous ovarian cancers (HGSOC) from 2004–2019. The secondary objective was to an
Externí odkaz:
https://doaj.org/article/87167dc5edf64399bbd50c4464f0103c
Autor:
Anna V. Tinker, Alon D. Altman, Marcus Q. Bernardini, Prafull Ghatage, Lilian T. Gien, Diane Provencher, Shannon Salvador, Sarah Doucette, Amit M. Oza
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4354-4369 (2022)
The majority of patients with advanced, high-grade epithelial-tubo ovarian cancer (EOC) respond well to initial treatment with platinum-based chemotherapy; however, up to 80% of patients will experience a recurrence. Poly(ADP-ribose) Polymerase (PARP
Externí odkaz:
https://doaj.org/article/fe8a21f7885c4aed92258cf4d73a89b6
Autor:
Alicia Tone, Talin Boghosian, Alison Ross, Elisabeth Baugh, Alon D. Altman, Lesa Dawson, Frances Reid, Cailey Crawford
Publikováno v:
Current Oncology, Vol 29, Iss 5, Pp 3318-3340 (2022)
The Every Woman StudyTM: Canadian Edition is the most comprehensive study to date exploring patient-reported experiences of ovarian cancer (OC) on a national scale. An online survey conducted in Fall 2020 included individuals diagnosed with OC in Can
Externí odkaz:
https://doaj.org/article/a494f1c99a5c45d6a6197c4b202f3d6e
Autor:
Anna V. Tinker, Neesha C. Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouëlian, Stephen A. Welch, Alon D. Altman
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background and objectives: Endometrial cancer is a common malignancy and recurrences can be fatal. Although platinum-pretreated endometrial tumors are commonly treated with anthracyclines and taxanes, there is no current standard of care. Both immune
Externí odkaz:
https://doaj.org/article/39f2a9177c624dc4966f99714f895875
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100702- (2021)
Externí odkaz:
https://doaj.org/article/c6389e57290a487fa64e76d1405ad5ca
Publikováno v:
Gynecologic Oncology Reports, Vol 20, Iss C, Pp 112-114 (2017)
Externí odkaz:
https://doaj.org/article/c0efb721ef7347ac8a0be63849cba39b
Publikováno v:
Gynecologic Oncology. 170:54-58